BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26796203)

  • 1. Changes in structure and function of diaphragm neuromuscular junctions from BACHD mouse model for Huntington's disease.
    de Aragão BC; Rodrigues HA; Valadão PA; Camargo W; Naves LA; Ribeiro FM; Guatimosim C
    Neurochem Int; 2016 Feb; 93():64-72. PubMed ID: 26796203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular synapse degeneration without muscle function loss in the diaphragm of a murine model for Huntington's Disease.
    Valadão PAC; Gomes MPSM; Aragão BC; Rodrigues HA; Andrade JN; Garcias R; Joviano-Santos JV; Luiz MA; Camargo WL; Naves LA; Kushmerick C; Cavalcante WLG; Gallacci M; de Jesus ICG; Guatimosim S; Guatimosim C
    Neurochem Int; 2018 Jun; 116():30-42. PubMed ID: 29530757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etomidate evokes synaptic vesicle exocytosis without increasing miniature endplate potentials frequency at the mice neuromuscular junction.
    Valadão PA; Naves LA; Gomez RS; Guatimosim C
    Neurochem Int; 2013 Nov; 63(6):576-82. PubMed ID: 24044896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the neuromuscular junction in a middle-aged mouse model of congenital myasthenic syndrome.
    Leite Schetino LP; de Castro Fonseca M; Magalhães Gomes MPS; Costa Valadão PA; de Camargo WL; Rodrigues HA; Andrade JN; Arantes-Costa FM; Naves LA; Prado CM; Prado VF; Prado MAM; Guatimosim C
    Muscle Nerve; 2019 Dec; 60(6):790-800. PubMed ID: 31531871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.
    King AC; Wood TE; Rodriguez E; Parpura V; Gray M
    Exp Neurol; 2020 Aug; 330():113358. PubMed ID: 32387649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
    Spampanato J; Gu X; Yang XW; Mody I
    Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease.
    Rozas JL; Gómez-Sánchez L; Tomás-Zapico C; Lucas JJ; Fernández-Chacón R
    J Neurosci; 2011 Jan; 31(3):1106-13. PubMed ID: 21248135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease.
    Valadão PA; de Aragão BC; Andrade JN; Magalhães-Gomes MP; Foureaux G; Joviano-Santos JV; Nogueira JC; Ribeiro FM; Tapia JC; Guatimosim C
    Eur J Neurosci; 2017 Mar; 45(6):785-796. PubMed ID: 27992085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.
    Khedraki A; Reed EJ; Romer SH; Wang Q; Romine W; Rich MM; Talmadge RJ; Voss AA
    J Neurosci; 2017 Aug; 37(34):8077-8091. PubMed ID: 28724748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease.
    Valadão PAC; Oliveira BDS; Joviano-Santos JV; Vieira ÉLM; Rocha NP; Teixeira AL; Guatimosim C; de Miranda AS
    Life Sci; 2019 Sep; 232():116653. PubMed ID: 31302194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TrkB kinase activity maintains synaptic function and structural integrity at adult neuromuscular junctions.
    Mantilla CB; Stowe JM; Sieck DC; Ermilov LG; Greising SM; Zhang C; Shokat KM; Sieck GC
    J Appl Physiol (1985); 2014 Oct; 117(8):910-20. PubMed ID: 25170066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission.
    Eguchi T; Tezuka T; Fukudome T; Watanabe Y; Sagara H; Yamanashi Y
    Biochem Biophys Res Commun; 2020 Feb; 523(1):214-219. PubMed ID: 31848047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-type Ca
    Silva FR; Miranda AS; Santos RPM; Olmo IG; Zamponi GW; Dobransky T; Cruz JS; Vieira LB; Ribeiro FM
    Neurobiol Aging; 2017 Jul; 55():1-10. PubMed ID: 28391067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
    Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
    J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.
    Whittaker DS; Loh DH; Wang HB; Tahara Y; Kuljis D; Cutler T; Ghiani CA; Shibata S; Block GD; Colwell CS
    J Biol Rhythms; 2018 Oct; 33(5):535-554. PubMed ID: 30084274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.
    Gu Y; Pope A; Smith C; Carmona C; Johnstone A; Shi L; Chen X; Santos S; Bacon-Brenes CC; Shoff T; Kleczko KM; Frydman J; Thompson LM; Mobley WC; Wu C
    Neurobiol Dis; 2024 Jun; 195():106502. PubMed ID: 38608784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d.
    Spaulding EL; Sleigh JN; Morelli KH; Pinter MJ; Burgess RW; Seburn KL
    J Neurosci; 2016 Mar; 36(11):3254-67. PubMed ID: 26985035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5α-cholestan-3-one on the synaptic vesicle cycle at the mouse neuromuscular junction.
    Kasimov MR; Giniatullin AR; Zefirov AL; Petrov AM
    Biochim Biophys Acta; 2015 May; 1851(5):674-85. PubMed ID: 25725358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.